Kronox Lab Sciences declares ₹0.50 per share final dividend for FY26

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Final dividend of ₹0.50 per equity share approved for FY26
  • Jogindersingh Jaswal reappointed as director by rotation
  • Audited financial statements for FY26 adopted by shareholders
  • Cost auditor remuneration for FY27 ratified
powered bylight_fuzz_icon
51105926

*this image is generated using AI for illustrative purposes only.

Kronox Lab Sciences shareholders approved a final dividend of ₹0.50 per equity share for FY26 during the company’s 17th annual general meeting on September 16, 2026.

The meeting, conducted via video conferencing, also saw the reappointment of Jogindersingh Jaswal as director by rotation and the ratification of cost auditor remuneration for FY27.

Key Resolutions Passed

Shareholders approved four ordinary resolutions during the proceedings:

  • Adoption of audited financial statements for the fiscal year ended March 31, 2026
  • Declaration of a final dividend of ₹0.50 per equity share for FY26
  • Reappointment of Jogindersingh Jaswal (DIN: 02385809) as director
  • Ratification of remuneration payable to cost auditors for FY27

Management Presence

Jogindersingh Jaswal, chairman and managing director, presided over the meeting. Other directors present included Ketan Ramani, Pritesh Ramani, Kratika Negandhi, Parth Shah, and Satish Kumar.

Key managerial personnel Samir Gadhiya (chief financial officer) and Nikhil Goswami (company secretary) attended via VC. Statutory auditor Mahesh Udhwani, internal auditor Jaimin Modi, and secretarial auditor Devesh Pathak were also present.

Voting Process

The company secretary confirmed that quorum was present through VC/OAVM facilities provided by Kfin Technologies Limited. Members who had not voted electronically before the meeting were given 15 minutes after its conclusion to cast their votes. Results will be disseminated to stock exchanges and posted on the company website by September 18, 2026.

Historical Stock Returns for Kronox Lab Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
+0.69%-1.97%+13.95%+50.97%-2.39%+7.66%

How does the ₹0.50 dividend payout compare to Kronox Lab Sciences' historical dividend yield and peer averages in the clinical research sector?

What strategic initiatives or capital allocation plans has management outlined for FY27 following the ratification of cost auditor remuneration?

Could the reappointment of Jogindersingh Jaswal signal any upcoming shifts in corporate governance or leadership succession planning?

Kronox Lab Sciences schedules 17th AGM for September 16, 2026

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Kronox Lab Sciences schedules its 17th AGM for September 16, 2026
  • Board proposes a final dividend of ₹0.50 per equity share for FY26
  • Shareholders to approve reappointment of director Jogindersingh Jaswal
  • Remote e-voting facility available from September 13 to September 15, 2026
powered bylight_fuzz_icon
49135156

*this image is generated using AI for illustrative purposes only.

Kronox Lab Sciences has scheduled its 17th Annual General Meeting for September 16, 2026. The meeting will be held via video conferencing to transact ordinary and special business items.

The Board of Directors proposes a final dividend of ₹0.50 per equity share for the financial year ended March 31, 2026 (FY26). Shareholders will also consider the reappointment of Mr. Jogindersingh Jaswal as a director.

Key Agenda Items

The notice outlines specific resolutions for shareholder approval during the virtual meeting:

  • Adoption of the Audited Standalone Financial Statements for FY26.
  • Declaration of the final dividend.
  • Reappointment of Mr. Jogindersingh Jaswal, who retires by rotation.
  • Ratification of remuneration for Cost Auditors M/s. Diwanji & Associates.

Director Reappointment Details

Mr. Jogindersingh Jaswal seeks reappointment after serving since November 18, 2008. He holds a 26.39% stake in the company and draws an annual remuneration of ₹132 lakh. His expertise covers production, quality control, and human resources.

Cost Auditor Remuneration

The Board recommends ratifying the appointment of M/s. Diwanji & Associates as Cost Auditors for FY27. The proposed remuneration is fixed at ₹90,000 per annum plus applicable taxes. No directors or key managerial personnel have any financial interest in this resolution.

Meeting Logistics

The meeting will commence at 11:00 am on September 16, 2026. Remote e-voting will be available from September 13 to September 15, 2026. The cut-off date for voting rights is September 9, 2026. Share transfer books will remain closed from September 10 to September 16, 2026.

Historical Stock Returns for Kronox Lab Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
+0.69%-1.97%+13.95%+50.97%-2.39%+7.66%

How does the proposed ₹0.50 final dividend compare to Kronox Lab Sciences' payout ratio in previous years, and what does this signal about future capital allocation priorities?

Given Mr. Jogindersingh Jaswal's 26.39% stake and reappointment, how might his continued leadership influence the company's strategic direction in production and quality control for FY27?

What impact could the adoption of the FY26 Audited Standalone Financial Statements have on investor sentiment regarding the company's profitability and operational efficiency?

More News on Kronox Lab Sciences

1 Year Returns:-2.39%